52
Views
14
CrossRef citations to date
0
Altmetric
Review

Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility

&
Pages 841-855 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rajabrata Bhuyan & Alpana Seal. (2017) Dynamics and modulation studies of human voltage gated Kv1.5 channel. Journal of Biomolecular Structure and Dynamics 35:2, pages 380-398.
Read now
Gerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, Javier E Banchs, Erica Penny-Peterson, Robert Stevenson & Mario D Gonzalez. (2008) Vernakalant – a promising therapy for conversion of recent-onset atrial fibrillation. Expert Opinion on Investigational Drugs 17:5, pages 805-810.
Read now
Gerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, Javier E Banchs, Erica Penny-Peterson & Mario D Gonzalez. (2007) New antiarrhythmic treatment of atrial fibrillation. Expert Review of Cardiovascular Therapy 5:4, pages 707-714.
Read now

Articles from other publishers (11)

Chunxuan Wu, Jianhua Yan & Wei Li. (2022) Acacetin as a Potential Protective Compound against Cardiovascular Diseases. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-6.
Crossref
Rajabrata Bhuyan & Sajal Chakraborti. 2019. Oxidative Stress in Heart Diseases. Oxidative Stress in Heart Diseases 191 203 .
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases 17 28 .
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases 1 13 .
Hui-Jun Wu, Wei Wu, Hai-Ying Sun, Guo-Wei Qin, Hong-Bing Wang, Panwen Wang, Hari Krishna Yalamanchili, Junwen Wang, Hung-Fat Tse, Chu-Pak Lau, Paul M. Vanhoutte & Gui-Rong Li. (2011) Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain. Journal of Molecular and Cellular Cardiology 51:6, pages 966-973.
Crossref
Yi-mei Du, Xiao-xian Zhang, Dan-na Tu, Ning Zhao, Yan-jie Liu, Hua Xiao, Michael C. Sanguinetti, Anruo Zou & Yu-hua Liao. (2010) Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1. Journal of Molecular and Cellular Cardiology 48:6, pages 1111-1120.
Crossref
Martin Andér, Victor B. Luzhkov & Johan Åqvist. (2008) Ligand Binding to the Voltage-Gated Kv1.5 Potassium Channel in the Open State—Docking and Computer Simulations of a Homology Model. Biophysical Journal 94:3, pages 820-831.
Crossref
Iván A. Aréchiga, Gabriel F. Barrio-Echavarria, Aldo A. Rodríguez-Menchaca, Eloy G. Moreno-Galindo, Niels Decher, Martin Tristani-Firouzi, José A. Sánchez-Chapula & Ricardo A. Navarro-Polanco. (2008) Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block. Journal of Pharmacological Sciences 108:1, pages 49-55.
Crossref
Armando Lagrutta, Laszlo Kiss & Joseph J. Salata. 2008. Ion Channels. Ion Channels 145 168 .
Armando Lagrutta, Jixin Wang, Bernard Fermini & Joseph J. Salata. (2006) Novel, Potent Inhibitors of Human Kv1.5 K + Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current . Journal of Pharmacology and Experimental Therapeutics 317:3, pages 1054-1063.
Crossref
Heather M. Ross, Peter R. Kowey & Gerald V. Naccarelli. 2005. New Arrhythmia Technologies. New Arrhythmia Technologies 1 13 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.